Skip to main navigation
logo

Investor Relations

  • Overview
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • News & Events
    • News Releases
    • Investor Calendar
    • Presentations
  • Financial Information
    • SEC Filings
  • Governance
    • Governance Overview
    • Committee Composition
    • Board of Directors
    • Leadership
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

Presentations

Presentations

Biomarkers for Alzheimer’s Disease Summit 2021: Use of Novel Biomarkers of P. Gingivalis Infection & Neuroinflammation in the GAIN Trial
KOL Webinar Series Part 2: Innovations in in Alzheimer's Disease: Getting to the Root Cause of Neurodegeneration
CRTX AAIC Symposium Presentation
AAIC 2021 Poster Presentation: Increased Levels of Phospho-Tau217 in Neuron Cultures and CVN Mice Infected with P. Gingivalis
AAIC 2021 Poster Presentation: An Update and Baseline Data From The Phase 2/3 Gain Trial of Atuzaginstat (COR388)
KOL Webinar Series Part 1: Innovation in Periodontal Disease – A Major Unmet Medical Need
IADR 2021 Poster Presentation: "Gingipain Inhibitors Penetrate And Inhibit Gingipains In Porphyromonas gingivalis Biofilms" (July 23, 2021)
IADR 2021 Poster Presentation: "Novel lysine-gingipain inhibitor atuzaginstat (COR388) is efficacious in a mouse model of periodontal disease." (July 23, 2021)
ASCP 2021 Poster Presentation: “An Update and Baseline Data from the Phase 2/3 Gain Trial of COR388 (Atuzaginstat) a Novel Bacterial Virulence Factor Inhibitor for the Treatment of Alzheimer’s Disease” (June 1-4, 2021)
ASCP 2021 Oral Presentation: “An Update and Baseline Data from the Phase 2/3 Gain Trial of COR388 (Atuzaginstat) a Novel Bacterial Virulence Factor Inhibitor for the Treatment of Alzheimer’s Disease” (June 1-4, 2021)

Shareholder Tools

  • Print Page
  • RSS
  • E-mail Alerts
  • Search

© 2022 Cortexyme.     All rights reserved.

  • Facebook
  • Twitter
  • LinkedIn
  • Google+